UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported):
November 4, 2011


CHEMED CORPORATION
(Exact name of registrant as specified in its charter)

Registrant’s telephone number, including area code:
(513) 762-6900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01     Other Events

Chemed Corporation issued a press release on November 7, 2011 announcing its Board of Directors, at its November 4, 2011 meeting, formally authorized an additional $100 million for stock repurchase under Chemed’s existing share repurchase program.  These share repurchases will be funded through cash generated from operations as well as utilization of the company’s revolving credit facility.

The Board of Directors also declared a quarterly cash dividend of 16 cents per share on the Company’s capital stock, payable on December 7, 2011 to share holders of record as of November 17, 2011.

              A copy of the release is filed herewith as Exhibit 99

Item 9.01     Financial Statements and Exhibits

d)      Exhibit

(99) Registrant’s press release dated November 7, 2011                              

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

2 of 2

Exhibit 99

Chemed Corporation’s Board of Directors Authorizes $100 Million Stock Repurchase Program – Declares Quarterly Dividend of 16 Cents

CINCINNATI--(BUSINESS WIRE)--November 7, 2011--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

The Board of Directors also declared a quarterly cash dividend of 16 cents per share on the Company’s capital stock, payable on December 7, 2011, to shareholders of record as of November 17, 2011. This represents the 162^nd consecutive quarterly dividend paid by Chemed in its 40 years as a public company.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

CONTACT:
Chemed Corporation
David P. Williams, 513-762-6901